5.55
+0.06(+1.09%)
Currency In USD
| Previous Close | 5.49 |
| Open | 5.41 |
| Day High | 5.58 |
| Day Low | 5.35 |
| 52-Week High | 7.82 |
| 52-Week Low | 2.77 |
| Volume | 380,036 |
| Average Volume | 754,974 |
| Market Cap | 214.17M |
| PE | -3.99 |
| EPS | -1.39 |
| Moving Average 50 Days | 5.69 |
| Moving Average 200 Days | 4.1 |
| Change | 0.06 |
If you invested $1000 in Protara Therapeutics, Inc. (TARA) 10 years ago, it would be worth $9.49 as of December 28, 2025 at a share price of $5.55. Whereas If you bought $1000 worth of Protara Therapeutics, Inc. (TARA) shares 5 years ago, it would be worth $220.85 as of December 28, 2025 at a share price of $5.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Protara Announces Closing of $75 Million Public Offering
GlobeNewswire Inc.
Dec 08, 2025 9:05 PM GMT
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the closing of its underw
Protara Announces Pricing of $75 Million Public Offering
GlobeNewswire Inc.
Dec 05, 2025 3:03 AM GMT
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the pricing of its underw
Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
TARA-002 demonstrates 72% complete response rate at any time in BCG-Naïve patientsTARA-002 demonstrates a 69% complete response rate at the 6-month landmark and a 50% complete response rate at the 12-month landmark in BCG-Naïve patientsFavorable safe